Death Analysis 1.1
Interventions showed no clear difference in death Analysis 1.1 compared with control at end of intervention (low certainty).
1 finding from 1 review
Pregnancy‐related deaths · pregnant women
One intervention showed no clear difference in pregnancy‐related deaths compared with no intervention (low certainty).
1 finding from 1 review
All‐cause mortality (deaths) Â · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes all‐cause mortality (deaths) Â compared with usual care (very low certainty).
1 finding from 1 review
Death or dependence · adults with a brain arteriovenous malformation
Interventions probably leads to higher death or dependence compared with conservative management (moderate certainty).
1 finding from 1 review
Death · people with CKD
1 finding from 1 review
Pregnancy‐related deaths · pregnant women
Combination of interventions showed no clear difference in pregnancy‐related deaths compared with no intervention (moderate certainty).
1 finding from 1 review
Number of other deaths (unrelated to SUDEP) · cases of SUDEP and matched controls (number of deaths due to SUDEP) and consecutive people with epilepsy from a tertiary care teaching…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of deaths due to SUDEP: Nocturnal supervision compared to no supervision · cases of SUDEP and matched controls (number of deaths due to SUDEP) and consecutive people with epilepsy from a tertiary care teaching…
2 findings from 1 review
no estimate extracted
203 participants
Very low
OR 0.76 [0.4, 1.46]
48 participants
Very low
Number of deaths due to SUDEP: Special precautions compared to no special precautions · cases of SUDEP and matched controls (number of deaths due to SUDEP) and consecutive people with epilepsy from a tertiary care teaching…
It is very uncertain whether interventions for changes number of deaths due to SUDEP: special precautions compared to no… compared with no intervention (very low certainty).
1 finding from 1 review
OR 0.41 [0.2, 0.82]
155 participants
Very low
Death
Percutaneous vascular interventions showed no clear difference in death compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Maternal death · women with severe pre‐eclampsia between 24 and 34 weeks' gestation
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in death by any cause compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
Death · people with CKD
Educational interventions and self‐management training showed no clear difference in death compared with usual care (moderate certainty).
1 finding from 1 review
Perinatal mortality · women with severe pre‐eclampsia between 24 and 34 weeks' gestation
Interventionist care showed no clear difference in perinatal mortality or perinatal death compared with expectant (delayed delivery) care (low certainty).
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: death (secondary outcome) compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Death (any cause) · people with CKD who are overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total cardiac endpoints (all‐cause and cardiac deaths, myocardial infarction, hospital admissions for heart failure, unstable angina or stroke, unadjusted) · adults with established cardiovascular disease
It is very uncertain whether mediterranean dietary intervention changes total cardiac endpoints (all‐cause and cardiac deaths, myocardial… compared with another dietary intervention (very low certainty).
1 finding from 1 review
Adverse events: 1. death: at end of treatment · emotionalism after stroke
Pharmaceutical interventions showed no clear difference in adverse events: 1. death: at end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: death (secondary outcome) compared with placebo (very low certainty).
1 finding from 1 review